Abstracts tagged "Atherosclerosis"

Abstract Number: 706 • 2012 ACR/ARHP Annual Meeting
Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis
Amish J. Dave¹, Bharathi Lingala², David Fiorentino³, Eswar Krishnan⁴ and Lorinda Chung⁵, ¹Stanford University, Stanford, CA, ²Dermatology, Stanford University, Redwood City, CA, ³Dermatology, Stanford University School of Medicine, Redwood City, CA, ⁴Medicine, Standford University, Palo Alto, CA, ⁵Rheumatology, Stanford Univ Medical Center, Palo Alto, CA
Background/Purpose: Patients with autoimmune connective tissue diseases (CTD), including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), are at increased risk for atherosclerotic cardiovascular disease…
Abstract Number: 1537 • 2012 ACR/ARHP Annual Meeting
Pathogenesis of Atherosclerosis in Granulomatosis Polyangiitis
Rula Hajj-Ali¹, Roy L. Silverstein², Gary S. Hoffman³ and Carol A. Langford⁴, ¹Cleveland Clinic Foundation, Cleveland, OH, ²Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI, ³Rheumatic & Immunologic Dis, Cleveland Clinic Found A50, Cleveland, OH, ⁴Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH
Background/Purpose: Previous studies from our group suggested that the inflammatory events that occur during relapses in patients with Granulomatosis with Polyangiitis (GPA, Wegener’s) may have…
Abstract Number: 675 • 2012 ACR/ARHP Annual Meeting
Differential Impairment of Serum Cholesterol Efflux Capacity in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Pier Luigi Meroni¹, Nicoletta Ronda², Elda Favari³, Orietta Borghi⁴, Francesca Zimetti⁵, Mariapia Adorni⁶, Francesca Ingegnoli⁷, Maria Gerosa⁸, Claudia Grossi⁹ and Franco Bernini⁶, ¹Division of Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy, ²Department of Pharmacy, University of Parma, Parma, Italy, ³Department of Pharmacological and Biological Sciences,, University of Parma, Parma, Italy, ⁴Department of clinical and comunity sciences, University of Milan, Milan, Italy, ⁵Department of Pharmacological and Biological Sciences, University of Parma, Parma, Italy, ⁶Department of Pharmacological and Biological Sciences, 39-02-58318176, Parma, Italy, ⁷Dept. of clinical and community science, Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy, ⁸Department of Clinical Sciences and Community Health, University of Milan, Italy, Division of Rheumatology, Istituto Ortopedico Gaetano Pini,, Milan, Italy, ⁹Lab of immunology, IRCCS Istituto Auxologico Italiano, Milano, Italy
Background/Purpose: Accelerated atherosclerosis associated with autoimmune diseases is partly due to immune system dysregulation aggravating cardiovascular damage, but little is known on lipid metabolism derangement…
Abstract Number: 1386 • 2012 ACR/ARHP Annual Meeting
Genetic Variation and Coronary Atherosclerosis in Patients with Systemic Lupus Erythematosus
Cecilia P. Chung¹, Joseph F. Solus², Annette Oeser³, Chun Li⁴, Paolo Raggi⁵, Jeffrey R. Smith³ and C. Michael Stein⁶, ¹Medicine, Vanderbilt University School of Medcine, Nashville, TN, ²Medicine, Vanderbilt University, Nashville, TN, ³Vanderbilt University, Nashville, TN, ⁴Biostatistics, Vanderbilt University, Nashville, TN, ⁵University of Alberta, Edmonton, AB, Canada, ⁶Internal Medicine and Pharmacology, Vanderbilt University, Nashville, TN
Background/Purpose: Premature coronary artery disease is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). However, this is not explained…
Abstract Number: 677 • 2012 ACR/ARHP Annual Meeting
Antibodies to Oxidized Low Density Lipoprotein or Anti-Lipoprotein Lipase May Lead to More Atherosclerotic Plaque in a Sub-Set of SLE Patients
Biji T. Kurien¹, James Fesmire², Skyler P. Dillon³, Marianne Reichlin⁴, Morris Reichlin⁵ and Robert H. Scofield⁶, ¹College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ²Oklahoma Medical Research Foundation, ³Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁴Oklahoma Medical Res Fndn, Oklahoma City, OK, ⁵Arthritis & Imm Laboratory, Oklahoma Medical Research Foun, Oklahoma City, OK, ⁶Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK
Background/Purpose: Premature atherosclerosis is associated with systemic lupus erythematosus (SLE). Oxidized low density lipoproteins (oxLDL) are important in atherosclerosis and have been reported in SLE…
Abstract Number: 1258 • 2012 ACR/ARHP Annual Meeting
Association Between Low Vitamin D Levels and Indicators of Osteoporosis and Atherosclerosis
Barry J. Sheane¹, Ruth Dunne², Ken Scott³, Mary Hall⁴, Michelle O'Connor², Martin Healy⁵, John Feely⁴, J.B. Walsh⁶ and Gaye Cunnane⁷, ¹Dept. of Rheumatology, St. James's Hospital, Dublin, Ireland, ²Diagnostic Imaging Department, St James's Hospital, Dublin, Ireland, ³Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin 8, Ireland, ⁴Department of Pharmacology and Therapeutics, St James's Hospital, Dublin, Ireland, ⁵Central Pathology Laboratory, St James's Hospital, Dublin, Ireland, ⁶Medicine for the Elderly, St James's Hospital, Dublin, Ireland, ⁷Dept of Rheumatology, St James's Hospital, Dublin, Ireland
Background/Purpose: Osteoporosis and cardiovascular disease are complications of chronic rheumatoid arthritis (RA). It is not known if these processes share pathogenetic mechanisms. Low levels of…
Abstract Number: 681 • 2012 ACR/ARHP Annual Meeting
Interferon Alpha Decreases Endothelial Nitric Oxide Synthase Function and Expression in Human Umbilical Vein Endothelial Cells
Joy Buie¹ and Jim Oates², ¹Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, ²Medicine, Medical University of South Carolina, Charleston, SC
Background/Purpose: Premenopausal SLE patients have a devastating increase in cardiovascular disease (CVD) and major associated cardiovascular events (MACE) that are not fully explained by Framingham…
Abstract Number: 1259 • 2012 ACR/ARHP Annual Meeting
Association Between Subclinical Atherosclerosis and Bone Mineral Density in Rheumatoid Arthritis
Barry J. Sheane¹, Ruth Dunne², Ken Scott³, Mary Hall⁴, Michelle O'Connor², Martin Healy⁵, John Feely⁴, J.B. Walsh⁶ and Gaye Cunnane⁷, ¹Rheumatology, St. James Hospital, Dublin, Ireland, ²Diagnostic Imaging Department, St James's Hospital, Dublin 8, Ireland, ³Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin 8, Ireland, ⁴Department of Pharmacology and Therapeutics, St James's Hospital, Dublin 8, Ireland, ⁵Central Pathology Laboratory, Dublin 8, Ireland, ⁶Medicine for the Elderly, Dublin 8, Ireland, ⁷Dept of Rheumatology, St James's Hospital, Dublin, Ireland
Background/Purpose: Rheumatoid arthritis (RA) is associated with a higher risk of osteoporosis (OP) and cardiovascular disease (CVD). This cross-sectional study was undertaken to identify links…
Abstract Number: 647 • 2012 ACR/ARHP Annual Meeting
Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus: Results from an Inception Cohort Followed for Eight Years
Murray B. Urowitz¹, Dominique Ibanez¹, D. D. Gladman², SLICC³ and Systemic Lupus International Collaborating Clinics (SLICC)³, ¹Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ³Division of Rheumatology, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose : There is a high prevalence of premature atherosclerosis among patients with SLE, with a risk 7-9 times that of the general population. The…
Abstract Number: 1261 • 2012 ACR/ARHP Annual Meeting
Epicardial Adipose Tissue Is Associated with Cardiometabolic Risk and the Metabolic Syndrome in Patients with Rheumatoid Arthritis
Michelle J. Ormseth¹, Aliza Lipson², Nikolaos Alexopoulos³, Gregory R. Hartlage³, Annette M. Oeser⁴, Aihua Bian⁴, Tebeb Gebretsadik⁵, Ayumi Shintani⁴, Paolo Raggi⁶ and C. Michael Stein⁷, ¹Rheumatology, Vanderbilt Medical Center, Nashville, TN, ²Rheumatology, Emory University, Atlanta, GA, ³Emory University, Atlanta, GA, ⁴Vanderbilt Medical Center, Nashville, TN, ⁵Biostatistics, Vanderbilt University, Nashville, TN, ⁶University of Alberta, Edmonton, AB, Canada, ⁷School of Medicine, Division of Clinical Pharmacology, Vanderbilt Medical Center, Nashville, TN
Background/Purpose: Patients with rheumatoid arthritis (RA) have increased coronary atherosclerosis and this may be related to their increased prevalence of visceral adiposity, insulin resistance, and…
Abstract Number: 629 • 2012 ACR/ARHP Annual Meeting
Inflammatory Biomarkers of Atherosclerosis and Oxidative Stress Are Associated with Disease Flare in SLE
Maureen A. McMahon¹, Jennifer M. Grossman¹, Brian Skaggs², Elaine Lourenco², Cheryl Lee¹, Lori Sahakian³, John FitzGerald⁴, Christina Charles-Schoeman⁵, Alan H. Gorn⁶, George A. Karpouzas⁷, Michael H. Weisman⁸, Daniel J. Wallace⁹, Weiling Chen¹ and Bevra H. Hahn⁶, ¹Div of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ²Medicine/Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ³Division of Rheumatology, Department of Medicine,, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁴Medicine-Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁵University of California, Los Angeles, CA, ⁶Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁷Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ⁸Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁹Cedars-Sinai Medical Center, Los Angeles, CA
Background/Purpose: Although our current serologic measures of disease activity are useful for predicting flare in some patients, other patients experience disease flare in the absence…
Abstract Number: 1262 • 2012 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Patients with Higher Disease Severity and Subclinical Carotid Plaque Experience More Cardiovascular Events Despite a Favorable Conventional Cadiovascular Risk Profiles
Yeon-Ah Lee¹, Somi Kim¹, Sang-Hoon Lee², Ran Song², Hyung In Yang² and Seung-Jae Hong¹, ¹Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, ²Rheumatology, Hospital at GANGDONG, Kyung Hee University, Seoul, South Korea
Background/Purpose: It has been shown that patients with rheumatoid arthritis (RA) experience cardiovascular (CV) events more often than expected. Increased risks of CV diseases in…
Abstract Number: 596 • 2012 ACR/ARHP Annual Meeting
Evolution of Atherosclerosis in Psoriatic Arthritis: Is the Former an Independent Inflammatory Process?
Roberta Ramonda¹, Massimo Puato², Valentina Modesti³, Mariagrazia Lorenzin⁴, Paola Frallonardo⁴, Augusta Ortolan⁴, Carla Campana³, Alessandro Lo Nigro³ and Leonardo Punzi⁵, ¹Rheumatology Unit, University of Padova, Padova, Italy, ²Department of Internal Medicine, University of Padova, Padova, Italy, ³Unit of Rheumatology, University of Padova, Padova, Italy, ⁴Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy, ⁵Clinical and Experimental Medicine, Rheumatology Unit - University of Padova, Padova, Italy
Background/Purpose: A non-invasive study focusing on the structural and functional properties of the carotid arteries was carried out in psoriatic arthritis (PsA) patients. Increased cardiovascular…
Abstract Number: 1267 • 2012 ACR/ARHP Annual Meeting
Inflammatory Burden Predicts Progression of Carotid Plaque in Rheumatoid Arthritis: A 24-Month Longitudinal Analysis
Churl Hyun Im¹, Na Ri Kim¹, Jong Wan Kang¹, Young Ji Kim¹, Kyung Hye Kim¹, Eon Jeong Nam¹ and Young Mo Kang², ¹Internal Medicine (Rheumatology), Kyungpook National University School of Medicine, Daegu, South Korea, ²Department of Internal Medicine (Rheumatology), Kyungpook National University School of Medicine, Daegu, South Korea
Background/Purpose: Carotid atherosclerosis, which is associated with the increased risk of cardiovascular (CV) disease, is increased in rheumatoid arthritis (RA) patients. In our previous study,…
Abstract Number: 2663 • 2012 ACR/ARHP Annual Meeting
A Variant in the Osteoprotegerin Gene Is Associated with Coronary Atherosclerosis in Patients with Rheumatoid Arthritis: Results From a Candidate Gene Study
Cecilia P. Chung¹, Joseph F. Solus², Annette M. Oeser³, Chun Li⁴, Paolo Raggi⁵, Jeffrey R. Smith³ and C. Michael Stein³, ¹Medicine, Vanderbilt University, Nashville, TN, ²Medicine, Vanderbilt Medical Center, Nashville, TN, ³Vanderbilt University, Nashville, TN, ⁴Biostatistics, Vanderbilt University, Nashville, TN, ⁵Emory University, Atlanta, GA
Background/Purpose: Patients with rheumatoid arthritis (RA) have accelerated atherosclerosis. However, this association is not fully explained by traditional cardiovascular risk factors or markers of inflammation. Little is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].